|
Name |
2-Isopropyl-3-methoxycinnamic acid
|
| Molecular Formula | C13H16O3 | |
| IUPAC Name* |
(E)-3-(3-methoxy-2-propan-2-ylphenyl)prop-2-enoic acid
|
|
| SMILES |
CC(C)C1=C(C=CC=C1OC)/C=C/C(=O)O
|
|
| InChI |
InChI=1S/C13H16O3/c1-9(2)13-10(7-8-12(14)15)5-4-6-11(13)16-3/h4-9H,1-3H3,(H,14,15)/b8-7+
|
|
| InChIKey |
QWXXXRFASGFHKU-BQYQJAHWSA-N
|
|
| Synonyms |
2-ISOPROPYL-3-METHOXYCINNAMIC ACID; BSPBio_002665; SPECTRUM100756; SCHEMBL2280935; CHEMBL1451186; (E)-3-(3-methoxy-2-propan-2-ylphenyl)prop-2-enoic acid; CHEBI:166653; CCG-39842; SDCCGMLS-0066405.P001; NCGC00095455-01; NCGC00095455-02; BRD-K11813414-001-02-4; (E)-3-(2-isopropyl-3-methoxy-phenyl)prop-2-enoic acid
|
|
| CAS | NA | |
| PubChem CID | 5827643 | |
| ChEMBL ID | CHEMBL1451186 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 220.26 | ALogp: | 3.0 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 46.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 16 | QED Weighted: | 0.787 |
| Caco-2 Permeability: | -4.556 | MDCK Permeability: | 0.00002460 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.082 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.017 |
| 30% Bioavailability (F30%): | 0.003 |
| Blood-Brain-Barrier Penetration (BBB): | 0.321 | Plasma Protein Binding (PPB): | 81.33% |
| Volume Distribution (VD): | 0.301 | Fu: | 14.89% |
| CYP1A2-inhibitor: | 0.568 | CYP1A2-substrate: | 0.519 |
| CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.794 |
| CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.946 |
| CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.344 |
| CYP3A4-inhibitor: | 0.01 | CYP3A4-substrate: | 0.13 |
| Clearance (CL): | 9.383 | Half-life (T1/2): | 0.913 |
| hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.111 |
| Drug-inuced Liver Injury (DILI): | 0.114 | AMES Toxicity: | 0.027 |
| Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.262 |
| Skin Sensitization: | 0.736 | Carcinogencity: | 0.734 |
| Eye Corrosion: | 0.955 | Eye Irritation: | 0.984 |
| Respiratory Toxicity: | 0.3 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001101 | ![]() |
0.473 | D01ZJK | ![]() |
0.345 | ||
| ENC001547 | ![]() |
0.434 | D0V9EN | ![]() |
0.345 | ||
| ENC001030 | ![]() |
0.415 | D03LGG | ![]() |
0.316 | ||
| ENC001441 | ![]() |
0.411 | D0U5CE | ![]() |
0.316 | ||
| ENC002213 | ![]() |
0.393 | D0A3HB | ![]() |
0.305 | ||
| ENC004091 | ![]() |
0.390 | D0E9CD | ![]() |
0.304 | ||
| ENC002881 | ![]() |
0.367 | D09GYT | ![]() |
0.297 | ||
| ENC000471 | ![]() |
0.364 | D0E6OC | ![]() |
0.294 | ||
| ENC004379 | ![]() |
0.358 | D06REO | ![]() |
0.291 | ||
| ENC000168 | ![]() |
0.352 | D01PJR | ![]() |
0.290 | ||